Skip to main content
Clinical Trials/CTRI/2023/03/051094
CTRI/2023/03/051094
Not yet recruiting
Phase 2

A Clinical study to evaluate efficacy and safety of Softovac Liquifibre in the Management of Functional Constipation and Irregular Bowel Habit-An Open Label, Randomized, Comparative, Multi centric, Interventional, Prospective, Clinical Study - NI

upin Limited0 sites0 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Health Condition 1: K590- Constipation
Sponsor
upin Limited
Status
Not yet recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional

Investigators

Sponsor
upin Limited

Eligibility Criteria

Inclusion Criteria

  • 1\. Male or female subjects between the age group of 18 to 70 years (Cohort 1\) and 6 to 15 years (Cohort 2\)
  • Subjects diagnosed as per the Rome IV diagnostic criteria for Functional constipation, 2016 (Cohort 1\) and ROME IV Criteria for Functional Constipation (H3a) (Cohort 2\)
  • 3\. Subjects who are ready to provide written informed consent and who are ready to willingly participate and follow the protocol requirements of the clinical study.

Exclusion Criteria

  • Subjects diagnosed with colonic inertia.
  • 2\. Subjects who have recently undergone abdominal surgery
  • 3\. Subjects with history of anorectal surgery.
  • 4\.Subjects having other functional gastrointestinal disorders other than Functional constipation (i.e., IBS, Belching disorders etc.)
  • 5\. Subjects diagnosed with structural abnormalities of intestine
  • 6\. Subjects with uncontrolled DM and hypertension and Tuberculosis.
  • 7\. Known cases of HIV, tuberculosis, hypo and hyperthyroidism
  • 8\. Known cases of renal or liver dysfunction.
  • 9\. Subjects diagnosed with neurological problems
  • 10\. Subjects on chronic medication ( \>60 days) and/or who are on medications known to cause constipation.

Outcomes

Primary Outcomes

Not specified

Similar Trials